Clinical Trial Update: Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial [NA]

View source ↗

Summary

This entry reports on a single-arm, open-label trial evaluating almonertinib in combination with stereotactic body radiotherapy for EGFR-mutant non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Almonertinib (almonertinib)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: Non-small Cell Lung Cancer | NA | Status: RECRUITING